Practicing at the National Cancer Institute as a medical oncologist, Dr. Raffit Hassan graduated from the University of Kashmir, in India, in 1988. He completed his residency after moving to the United States, at the Sisters of Charity Hospital in Buffalo. He completed his fellowship at the National Cancer Institute in Bethesda where he is practicing today. Dr. Hassan specializes in a few specific types of cancer, including mesothelioma, for which he also conducts research and clinical trials. Developing a specific immunotoxin, SS1P, Dr. Hassan helps improve treatment efficacy for mesothelioma patients.
University of Kashmir, Hazratbal, India - 1988
Sisters of Charity Hospital, Buffalo, NY
National Cancer Institute, Bethesda, MD
American Board of Internal Medicine - Oncology
Antibody-drug conjugates for cancer therapy.
Thomas, A.,Teicher, B. A.,Hassan, R.; Lancet Oncol.See more >>
Recombinant Immunotoxin with T-cell Epitope Mutations That Greatly Reduce Immunogenicity for Treatment of Mesothelin-Expressing Tumors.
Mazor R1, Zhang J1, Xiang L1, Addissie S1, Awuah P1, Beers R1, Hassan R1, PastanSee more >>
American Society of Clinical Oncology
Mesothelioma Applied Research Foundation